ENTITY
Aarti Drugs Ltd

Aarti Drugs Ltd (ARTD IN)

23
Analysis
Health CareIndia
Aarti Drugs Limited is a pharmaceutical company which manufactures bulk drugs and specialty chemicals. The Company's products include vitamins and sedatives, as well as anti-inflammatory, anti-asthma, anti-arthritis, anti-fungal, anti-diabetic, anti-osteoporosis, anti-cholinergic and anti-depressant drugs. The company sells its products in India and elsewhere throughout the world.
more
bullishAarti Drugs Ltd
06 Feb 2025 11:30

The Beat Ideas: Aarti Drugs Revival

​US FDA approvals for Tarapur & Baddi facilities will boost revenues and margins, allowing entry into regulated US market and expanding market...

Logo
431 Views
Share
bearishSagility India
26 May 2025 22:46

Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

Sagility B.V. plans to offload up to 15.02% stake in Sagility India via block deals worth INR26.7bn (US$314.7m). The secondary share sale is priced...

Logo
938 Views
Share
07 Apr 2025 14:52

Capex Monetization: Revenue Impact, Margin Expansion Across Companies

​Companies are expanding capacity to meet strong demand, improve financial performance, and create long-term value, positioning them for...

Logo
420 Views
Share
bullishAarti Drugs Ltd
12 Sep 2020 14:27

India Small Caps: Position for Outperformance Vs Large & Mid Caps

Late Friday evening, the Securities and Exchange Board of Indian 

Logo
694 Views
Share
22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Share
x